Efficacy News and Research

RSS
New biomarker for pancreatic cancer effectively targets potential therapy for small survival rate

New biomarker for pancreatic cancer effectively targets potential therapy for small survival rate

Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Cynvenio launches ClearID Breast Cancer monitoring program

Cynvenio launches ClearID Breast Cancer monitoring program

Two 90-minute group sessions in high schools reduce mental health problems in teens

Two 90-minute group sessions in high schools reduce mental health problems in teens

New method to monitor activity of gene promoters during response to drug

New method to monitor activity of gene promoters during response to drug

Cambridge Consultants helps MSF’s efforts to widen access to HIV viral load tests

Cambridge Consultants helps MSF’s efforts to widen access to HIV viral load tests

Study suggests that surgery may be effective treatment for epilepsy in older patients

Study suggests that surgery may be effective treatment for epilepsy in older patients

UCLA study shows how cocaine makes immune cells susceptible to HIV

UCLA study shows how cocaine makes immune cells susceptible to HIV

New agreement to expand scope of research project to evaluate MCT-485 for primary liver cancer

New agreement to expand scope of research project to evaluate MCT-485 for primary liver cancer

Adamas Pharmaceuticals reports positive results from ADS-5102 Phase 2/3 EASED clinical trial

Adamas Pharmaceuticals reports positive results from ADS-5102 Phase 2/3 EASED clinical trial

Klox Biophotonic System gets approval in Canada for treatment of acne vulgaris

Klox Biophotonic System gets approval in Canada for treatment of acne vulgaris

Researchers develop new approach to combat tubercle bacillus

Researchers develop new approach to combat tubercle bacillus

Final patient completion of phase II study of TR040303 in patients treated for acute myocardial infarction announced by Trophos

Final patient completion of phase II study of TR040303 in patients treated for acute myocardial infarction announced by Trophos

Data from Boehringer Ingelheim's HCV clinical program accepted for presentation at The Liver Meeting

Data from Boehringer Ingelheim's HCV clinical program accepted for presentation at The Liver Meeting

FDA grants accelerated approval to Perjeta for neoadjuvant treatment of breast cancer

FDA grants accelerated approval to Perjeta for neoadjuvant treatment of breast cancer

Emotion regulation training enhances efficacy of inpatient cognitive behavioral therapy for MDD

Emotion regulation training enhances efficacy of inpatient cognitive behavioral therapy for MDD

Stem cell-enriched fat grafting may prove an attractive option to major tissue augmentation

Stem cell-enriched fat grafting may prove an attractive option to major tissue augmentation

AcelRx Pharmaceuticals submits Zalviso NDA to FDA

AcelRx Pharmaceuticals submits Zalviso NDA to FDA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.